Shots: Roche has launched Elecsys SARS-CoV-2 Ag test as an aid in the diagnosis of SARS-CoV-2 infections, in the markets accepting the CE Mark. Additionally, Roche has also filed a EUA to the US FDA The test showed 94.5% sensitivity across 200 PCR confirmed symptomatic individuals & 99.9% specificity across 2747 PCR negative symptomatic & […]Read More
Shots: Roche plans to launch a high-volume SARS-CoV-2 Antigen test to aid the diagnosis of SARS-CoV-2 infection. Roche intends to file US FDA’s EUA while the test is expected to be available at the end of 2020 for markets accepting the CE Mark The test will run on all Roche cobas e immunochemistry analyzers and […]Read More
Shots: GSK, AstraZeneca and the University of Cambridge have formed a collaboration, supporting the UK’s government five-pillar plan to boost testing for COVID-19 A new testing laboratory will be set up in the University’s Anne McLaren laboratory and will explore the use of alternative chemical reagents for high throughput screening for COVID-19 testing for overcoming […]Read More
Copyright ©2021 PharmaShots | Powered by Octavus Consulting
